HF  Maverick Capital

http://www.maverickcap.com





     Office Locations:

1 Letterman Drive
San Francisco, CA 94129
Phone: 415-441-1460

Get all office locations for this firm with a National Database subscription or New York Database subscription.
 

Stages:

  • Early


 

Industries:

  • Information Technology
  • Life Sciences & Healthcare
  • Media & Digital Media
  • Software & Internet

  •  

    Description:

    Maverick Capital is a global investment firm with offices in New York, San Francisco, London, Hong Kong, Philadelphia and Dallas. Maverick's investment team seeks to grow and preserve capital for its investors, primarily through a long/short hedged equity strategy. Since the Firm's inception in 1993, Maverick has strategically invested in private companies that represent disruptive business models or technologies. Maverick actively partners with portfolio company teams through the deployment of its resources and deep fundamental research capabilities to help entrepreneurs build their businesses.


     

    Funds:


      Fund Name


      Amount


      Date

    Get funds under management for this firm including Fund name, Dollar size of fund raise, and Vintage with a National Database subscription or New York Database subscription.



    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
       
       
       
    COMPANY STAGEREVENUE
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Revenue
    Growth Stage
    (also called Mid-stage)
    $2M-$7M
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B
       
       
     

    Investment Team:


    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription or New York Database subscription.
    Alex S. Rafal Managing Director and Security Analyst
    Brett Caughran Senior Analyst
    Corrie Mattorano
    Eric Kim Managing Director
    Evan Acton Wyly Managing Partner

     

    Recent Funding Events (trailing 12 months):


      Date


      Name


      State


      Amount


      Stage


      04/10/2024


      Auradine


      CA


      $80,000,000


      Series B


      04/04/2024


      SiMa.ai


      CA


      $70,000,000


      Venture


      02/13/2024


      Areteia Therapeutics


      NC


      $75,000,000


      Series A


     

    Portfolio companies include:


      Aptible
        web link


      Areteia Therapeutics
        web link


      Armune Bioscience
        web link


      Auradine
        web link


      Caribou Biosciences
        web link


      Castlight Health
        web link


      Clari


      Coherent
        web link


      One Medical Group
        web link


      Science Exchange
        web link


      SeeChange Health
        web link


      SiMa.ai
        web link


      Uptake
        web link


      Zenefits
        web link


     

    Recent News: